MarketPeel
Insider Trading Intelligence
TM

Thomas A. Mccourt

IRWD
CHIEF EXECUTIVE OFFICER · IRONWOOD PHARMACEUTICALS INC · CIK 0001478448
FILING MIX · LIFETIME36%/64%
BUYS
24
SELLS
42
TOTAL VALUE
$14.91M
COMPANIES
2
ACTIVE SINCE
Jan 2020
HOLDINGS NOW
1,968,838
AVG SELL PX
$9.36
TRADE KIND
SHOWING 66 / 66
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
37 backtested trades · 8 horizons · 8 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Thomas A. Mccourt, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d37+51.35%+0.94%-0.40%+1.34%-0.20%1.18
14d37+40.54%+2.97%-0.34%+3.30%+1.79%2.53
30d37+67.57%-1.59%-0.63%-0.97%+0.73%-0.46
60d37+51.35%-1.11%+0.52%-1.63%+0.77%-0.68
90d37+45.95%+0.43%+2.43%-2.20%-2.92%-0.56
180d37(2 pending)+57.14%+7.12%+5.76%+1.35%-11.97%0.10
1y37(2 pending)+51.43%+14.29%+15.18%-0.88%-9.61%-0.05
2y37(4 pending)+75.76%-33.88%+34.40%-68.28%-80.64%-6.49
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
IRWD · 1,898,838 shares · as of Mar 10, 2026
0474,710949,4191,424,1291,898,838202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 24 buys / 42 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
PLRX
PLIANT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
70,00070,000Jun 11, 2026Jun 12, 2026View →
IRWD
IRONWOOD PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
409,8361,898,838Mar 10, 2026Mar 12, 2026View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
Chief Executive Officer
103,526$3.66$378.9K1,489,002Feb 24, 2026Feb 25, 2026View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
Chief Executive Officer
94,757$3.81$361.0K1,592,528Feb 23, 2026Feb 25, 2026View →
PLRX
PLIANT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
30,00030,000Jun 5, 2025Jun 9, 2025View →
IRWD
IRONWOOD PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
540,0001,687,281May 20, 2025May 20, 2025View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
Chief Executive Officer
13,353$0.58$7.7K1,147,281May 16, 2025May 20, 2025View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
Chief Executive Officer
139,064$1.76$244.8K1,160,634Feb 10, 2025Feb 12, 2025View →
IRWD
IRONWOOD PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
147,3541,299,698Jan 17, 2025Jan 22, 2025View →
PLRX
PLIANT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
26,76426,764Jun 13, 2024Jun 17, 2024View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
Chief Executive Officer
67,618$6.45$436.1K1,150,330May 20, 2024May 22, 2024View →
IRWD
IRONWOOD PHARMACEUTICALS INC
PURCHASE
Chief Executive Officer
120,2981,217,948Mar 8, 2024Mar 12, 2024View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
Chief Executive Officer
120,2980Mar 8, 2024Mar 12, 2024View →
IRWD
IRONWOOD PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
264,8761,097,650Mar 5, 2024Mar 7, 2024View →
IRWD
IRONWOOD PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
132,438132,438Mar 5, 2024Mar 7, 2024View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
Chief Executive Officer
177,164$15.24$2.70M832,774Feb 12, 2024Feb 14, 2024View →
IRWD
IRONWOOD PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
249,6171,009,938Jan 17, 2024Jan 19, 2024View →
PLRX
PLIANT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
14,00014,000Jun 7, 2023Jun 8, 2023View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
26,632$10.70$285.0K758,284May 30, 2023Jun 1, 2023View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
Chief Executive Officer
36,000$10.12$364.3K784,916May 22, 2023May 24, 2023View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
Chief Executive Officer
21,148$10.62$224.6K820,916May 8, 2023May 10, 2023View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
Chief Executive Officer
46,129$10.67$492.2K842,064Mar 27, 2023Mar 29, 2023View →
IRWD
IRONWOOD PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
240,595888,193Mar 8, 2023Mar 10, 2023View →
IRWD
IRONWOOD PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
120,297120,297Mar 8, 2023Mar 10, 2023View →
PLRX
PLIANT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
22,00022,000Mar 6, 2023Mar 8, 2023View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
Chief Executive Officer
33,756$11.22$378.7K647,598Mar 3, 2023Mar 7, 2023View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
Chief Executive Officer
4,588$11.31$51.9K681,354Feb 28, 2023Mar 1, 2023View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
Chief Executive Officer
26,639$11.31$301.3K685,942Feb 28, 2023Mar 1, 2023View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
Chief Executive Officer
25,595$11.41$292.0K716,990Feb 27, 2023Mar 1, 2023View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
Chief Executive Officer
4,409$11.41$50.3K712,581Feb 27, 2023Mar 1, 2023View →
IRWD
IRONWOOD PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
30,145742,585Jan 17, 2023Jan 19, 2023View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
Chief Executive Officer
110,9620Jan 5, 2023Jan 9, 2023View →
IRWD
IRONWOOD PHARMACEUTICALS INC
PURCHASE
Chief Executive Officer
110,962$11.65$1.29M823,402Jan 5, 2023Jan 9, 2023View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
Chief Executive Officer
110,962$12.07$1.34M712,440Jan 5, 2023Jan 9, 2023View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
Chief Executive Officer
18,899$10.41$196.7K712,440Oct 3, 2022Oct 5, 2022View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
Chief Executive Officer
26,446$10.65$281.6K731,339Sep 1, 2022Sep 6, 2022View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
Chief Executive Officer
23,229$11.35$263.6K757,785Aug 1, 2022Aug 3, 2022View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
Chief Executive Officer
19,959$11.58$231.1K778,922Jun 30, 2022Jul 5, 2022View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
Chief Executive Officer
21,873$11.50$251.5K810,729May 23, 2022May 25, 2022View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
Chief Executive Officer
11,848$11.50$136.3K798,881May 23, 2022May 25, 2022View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
Chief Executive Officer
2,587$11.50$29.8K832,602May 23, 2022May 25, 2022View →
IRWD
IRONWOOD PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
248,869835,189Mar 8, 2022Mar 10, 2022View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
Chief Executive Officer
1,942$10.77$20.9K632,802Feb 28, 2022Mar 2, 2022View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
Chief Executive Officer
19,970$10.77$215.1K602,806Feb 28, 2022Mar 2, 2022View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
Chief Executive Officer
10,026$10.77$108.0K622,776Feb 28, 2022Mar 2, 2022View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
Chief Executive Officer
16,486$10.77$177.6K586,320Feb 28, 2022Mar 2, 2022View →
IRWD
IRONWOOD PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
60,290634,744Jan 19, 2022Jan 21, 2022View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
Chief Executive Officer
46,327$11.41$528.6K574,454Dec 22, 2021Dec 23, 2021View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
Chief Executive Officer
52,644$11.58$609.6K618,545Nov 23, 2021Nov 24, 2021View →
IRWD
IRONWOOD PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
104,690671,189Jun 7, 2021Jun 9, 2021View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
President and Interim CEO
1,716$12.25$21.0K566,499May 24, 2021May 26, 2021View →
IRWD
IRONWOOD PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
96,638568,215Mar 26, 2021Mar 30, 2021View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
President
2,582$9.11$23.5K483,680Feb 26, 2021Mar 2, 2021View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
President
10,265$9.11$93.5K471,577Feb 26, 2021Mar 2, 2021View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
President
1,838$9.11$16.7K481,842Feb 26, 2021Mar 2, 2021View →
IRWD
IRONWOOD PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
145,631486,262Feb 22, 2021Feb 24, 2021View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
President
99,9880Dec 14, 2020Dec 16, 2020View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
President
81,089$12.20$989.3K340,631Dec 14, 2020Dec 16, 2020View →
IRWD
IRONWOOD PHARMACEUTICALS INC
PURCHASE
President
99,988$9.89$988.9K421,720Dec 14, 2020Dec 16, 2020View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
President
1,697$10.35$17.6K319,847May 11, 2020May 13, 2020View →
IRWD
IRONWOOD PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
100,482321,544Feb 27, 2020Mar 2, 2020View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
President
2,312$11.63$26.9K222,927Feb 21, 2020Feb 25, 2020View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
President
1,865$11.63$21.7K221,062Feb 21, 2020Feb 25, 2020View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
President
20,0000Jan 24, 2020Jan 28, 2020View →
IRWD
IRONWOOD PHARMACEUTICALS INC
SALE
President
20,000$12.71$254.2K225,239Jan 24, 2020Jan 28, 2020View →
IRWD
IRONWOOD PHARMACEUTICALS INC
PURCHASE
President
20,000$10.02$200.4K245,239Jan 24, 2020Jan 28, 2020View →
Other insiders · IRWD
Loading peer insiders…
About this filer
CIK 0001478448
ROLE
Chief Executive Officer
PRIMARY
IRWD
COMPANIES
2
ACTIVE SINCE
Jan 2020
MARKETPEEL · /INSIDER/0001478448DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback